Two organ systems watched across every incretin-agonist programme

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Incretin-agonist trials routinely measure pancreatic enzymes and record gallbladder events because early signals and mechanistic plausibility made both a focus of regulatory attention. Across the class, modest enzyme elevations without pancreatitis are common and gallbladder events are increased, the latter plausibly linked to rapid weight loss. Phase 2 trials of retatrutide monitored both; their size limits what they can conclude.

Why these two systems

GLP-1 receptors are expressed in the pancreas, and early post-marketing reports raised a question about pancreatitis that large trials have since largely not supported, though monitoring continues. Rapid weight loss by any means increases gallstone formation, and gallbladder events are consistently more frequent in active arms of weight-loss trials.

Both are therefore pre-specified safety measures in every programme in the class.

What the class trials show

Asymptomatic increases in lipase and amylase are common and do not by themselves indicate pancreatitis. Confirmed pancreatitis has been rare and not clearly increased in large outcome trials. Gallbladder-related events — cholelithiasis, cholecystitis — are increased in active arms across the class, in proportion to weight lost.

These are class-level observations from trials of approved agents and are reflected in their labelling.

Retatrutide phase 2

The trials measured pancreatic enzymes and recorded gallbladder events as part of standard safety monitoring, and the papers report what was observed. With a few hundred participants, the trials can characterise enzyme changes and describe any events; they cannot estimate the rate of rare outcomes. That is a phase 3 and post-marketing question.

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

Why these two systems?

GLP-1 receptors are expressed in the pancreas, and early post-marketing reports raised a question about pancreatitis that large trials have since largely not supported, though monitoring continues. Rapid weight loss by any means increases gallstone formation, and gallbladder events are consistently more frequent in active arms of weight-loss trials.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.